• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Bayesian dose-finding designs for longitudinal toxicity data in molecularly targeted agents

Research Project

Project/Area Number 17K00045
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Statistical science
Research InstitutionTokyo Medical and Dental University (2020)
The University of Tokyo (2017-2019)

Principal Investigator

Hirakawa Akihiro  東京医科歯科大学, 医学部附属病院, 教授 (90609330)

Project Period (FY) 2017-04-01 – 2021-03-31
Project Status Completed (Fiscal Year 2020)
Budget Amount *help
¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
Fiscal Year 2019: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2018: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywords臨床試験デザイン / 臨床統計学 / ベイズ流デザイン / がん臨床試験 / 分子標的薬 / マスタープロトコル / バスケットデザイン / 用量探索デザイン / ベイズ統計学 / 用量探索法 / アダプティブデザイン
Outline of Final Research Achievements

We investigated longitudinal toxicity profile of molecularly targeted agents using the data of phase I trials conducted in U.S. National Cancer Institute. Based on the result of this analysis, we developed two dose-finding methods based on the Lasso method and relative dose intensity (RDI) for determining optimal dose of molecularly targeted drugs. Master protocol trials have been emerged in cancer clinical trials in recent times. We also developed a new statistical design for basket trials.

Academic Significance and Societal Importance of the Research Achievements

医薬品開発の効率化・迅速化を目的に、革新的臨床試験デザインの研究開発が進んでいる。本研究では、ベイズ統計学を利用した新しい臨床試験デザインを開発した。この成果は、本邦の医薬品開発に資するものであると考える。

Report

(5 results)
  • 2020 Annual Research Report   Final Research Report ( PDF )
  • 2019 Research-status Report
  • 2018 Research-status Report
  • 2017 Research-status Report
  • Research Products

    (18 results)

All 2020 2019 2018 Other

All Int'l Joint Research (3 results) Journal Article (9 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 9 results,  Open Access: 3 results) Presentation (5 results) (of which Int'l Joint Research: 5 results) Book (1 results)

  • [Int'l Joint Research] National Cancer Institute(米国)

    • Related Report
      2019 Research-status Report
  • [Int'l Joint Research] National Cancer Institute(米国)

    • Related Report
      2017 Research-status Report
  • [Int'l Joint Research]

    • Related Report
      2017 Research-status Report
  • [Journal Article] A Bayesian basket trial design accounting for uncertainties of homogeneity and heterogeneity of treatment effect among subpopulations.2020

    • Author(s)
      2.Asano J, Hirakawa A
    • Journal Title

      Pharmaceutical Statistics

      Volume: 19 Issue: 6 Pages: 975-1000

    • DOI

      10.1002/pst.2049

    • Related Report
      2020 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A dose-finding approach for genomic patterns in phase I trials.2020

    • Author(s)
      Kaneko S, Hirakawa A, Kakurai Y, Hamada C.
    • Journal Title

      Journal of Biopharmaceutical Statistics

      Volume: - Issue: 5 Pages: 834-853

    • DOI

      10.1080/10543406.2020.1744619

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] Pragmatic dose-escalation methods incorporating relative dose intensity assessment for molecularly targeted agents in phase I trials.2019

    • Author(s)
      Hirakawa A, Tanaka Y, Kaneko S.
    • Journal Title

      Contemporary Clinical Trial Communications

      Volume: 16 Pages: 100489-100489

    • DOI

      10.1016/j.conctc.2019.100489

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] A comparative study of longitudinal toxicities of cytotoxic drugs, molecularly targeted agents, immunomodulatory drugs, and cancer vaccines2019

    • Author(s)
      Hirakawa A, Sudo K, Yonemori K, Sadachi R, Kinoshita F, Kobayashi Y, Okuma SH, Kawachi A, Tamura K, Fujiwara Y, Rubinstein L, Takebe N.
    • Journal Title

      Clinical Pharmacology & Therapeutics

      Volume: 106 Issue: 4 Pages: 803-809

    • DOI

      10.1002/cpt.1442

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] がん臨床試験におけるベイズ流バスケットデザインの理論と実装2019

    • Author(s)
      平川晃弘,浅野淳一,佐藤宏征,橋本大哉,手良向聡
    • Journal Title

      計量生物学

      Volume: 39 Pages: 103-122

    • NAID

      130007644700

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] マスタープロトコルに基づくがん臨床試験2019

    • Author(s)
      平川晃弘,浅野淳一,佐藤宏征,手良向聡
    • Journal Title

      計量生物学

      Volume: 39 Pages: 85-101

    • NAID

      130007644694

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] Dose individualization and variable selection using Bayesian Lasso in early phase dose-finding trials2019

    • Author(s)
      Kakurai Y, Kaneko S, Hamada C, Hirakawa A
    • Journal Title

      Applied Statistics

      Volume: 68 Issue: 2 Pages: 445-460

    • DOI

      10.1111/rssc.12326

    • Related Report
      2018 Research-status Report
    • Peer Reviewed
  • [Journal Article] Master protocol trials in oncology: Review and new trial designs2018

    • Author(s)
      33.Hirakawa A, Asano J, Sato H, Teramukai S
    • Journal Title

      Contemporary Clinical Trial Communications

      Volume: 12 Pages: 1-8

    • DOI

      10.1016/j.conctc.2018.08.009

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trial.2018

    • Author(s)
      Hirakawa A, Yonemori K, Kinoshita F, Kobayashi Y, Okuma H. Kawachi A, Tamura K, Fujiwara Y, Rubinstein L, Harris PJ, Takebe N.
    • Journal Title

      Cancer Science

      Volume: 1 Issue: 1 Pages: 207-214

    • DOI

      10.1111/cas.13436

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] Dose-Finding Method for Molecularly Targeted Agents Incorporating the Relative Dose Intensity in Phase I Oncology Clinical Trials.2019

    • Author(s)
      Tanaka Y, Sozu T, Hirakawa A
    • Organizer
      ENAR 2019 Spring Meeting
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] Heterogeneity Assessment of Treatment Effect among Subpopulations in Basket Trials2019

    • Author(s)
      Sadachi R, Hirakawa A
    • Organizer
      ENAR 2019 Spring Meeting
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] A Basket Trial Design using Bayesian Model Averaging.2019

    • Author(s)
      Hirakawa A, Sadachi R
    • Organizer
      ENAR 2019 Spring Meeting
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] A clustering-based basket design2019

    • Author(s)
      Hirakawa A
    • Organizer
      3rd Pacific Rim Cancer Biostatistics Workshop
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] Utility of Bayesian single-arm design in new drug application for rare cancers in Japan: application to basket trial data2019

    • Author(s)
      Hirakawa A
    • Organizer
      6th International Society of Biopharmaceutical Statistics
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Book] Modern Dose-Finding Designs for Cancer Phase I Trials: Drug Combinations and Molecularly Targeted Agents2018

    • Author(s)
      Hirakawa, A., Sato, H., Daimon, T., Matsui, S.
    • Total Pages
      104
    • Publisher
      Springer
    • ISBN
      9784431555728
    • Related Report
      2017 Research-status Report

URL: 

Published: 2017-04-28   Modified: 2022-01-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi